|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2016 |
|
Main ID: |
NCT02242513 |
|
Date of registration:
|
10/09/2014 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Ultrasound-guided Pulsed Radiofrequency for Plantar Fasciitis
|
|
Scientific title:
|
Ultrasound-guided Pulsed Radiofrequency Stimulation of the Tibial Nerve for Plantar Fasciitis |
|
Date of first enrolment:
|
April 2014 |
|
Target sample size:
|
36 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02242513 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Taiwan
| | | | | | | |
|
Contacts
|
|
Name:
|
Liang-Cheng Chen, MD, MS |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Department of Physical Medicine and Rehabilitation, Tri-Service General Hospital, National Defense Medical Center, |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Heel pain more than 3 months
- Age more than 20 year-old
- The increased thickness of plantar fascile (>4mm) measured by sonography
- Must be conscious
- Not receive steroid or other injection in plantar fascile in past 6 months
Exclusion Criteria:
- Cancer of any site
- Coagulopathy
- Pregnancy
- Inflammation status
Age minimum:
20 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Plantar Fasciitis
|
|
Intervention(s)
|
|
Drug: Xylocaine
|
|
Device: Pulsed radiofrequency (PRF)
|
|
Primary Outcome(s)
|
|
Change from baseline of pain on 4th, 8th and 12th weeks after treatment.
[Time Frame: Baseline , 4th, 8th and 12th weeks after treatment.]
|
|
Secondary Outcome(s)
|
|
Change from baseline of functional improvement on 4th, 8th and 12th after treatment.
[Time Frame: Baseline , 4th, 8th and 12th weeks after treatment.]
|
|
Change from baseline of thickness of plantar fascile on 4th, 8th and 12th weeks after treatment.
[Time Frame: Baseline , 4th, 8th and 12th weeks after treatment.]
|
|
Secondary ID(s)
|
|
TSGH-C103-115
|
|
TSGHIRB-2-102-05-95
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|